BACKGROUND: The inflammatory response triggered by cardiac surgery with cardiopulmonary bypass (CPB) is a primary mechanism in the pathogenesis of postoperative myocardial infarction (PMI), a multifactorial disorder with significant inter-patient variability poorly predicted by clinical and procedural factors. We tested the hypothesis that candidate gene polymorphisms in inflammatory pathways contribute to risk of PMI after cardiac surgery. METHODS AND RESULTS: We genotyped 48 polymorphisms from 23 candidate genes in a prospective cohort of 434 patients undergoing elective cardiac surgery with CPB. PMI was defined as creatine kinase-MB isoenzyme level > or = 10x upper limit of normal at 24 hours postoperatively. A 2-step analysis strategy was used: marker selection, followed by model building. To minimize false-positive associations, we adjusted for multiple testing by permutation analysis, Bonferroni correction, and controlling the false discovery rate; 52 patients (12%) experienced PMI. After adjusting for multiple comparisons and clinical risk factors, 3 polymorphisms were found to be independent predictors of PMI (adjusted P<0.05; false discovery rate <10%). These gene variants encode the proinflammatory cytokine interleukin 6 (IL6 -572G>C; odds ratio [OR], 2.47), and 2 adhesion molecules: intercellular adhesion molecule-1 (ICAM1 Lys469Glu; OR, 1.88), and E-selectin (SELE 98G>T; OR, 0.16). The inclusion of genotypic information from these polymorphisms improved prediction models for PMI based on traditional risk factors alone (C-statistic 0.764 versus 0.703). CONCLUSIONS: Functional genetic variants in cytokine and leukocyte-endothelial interaction pathways are independently associated with severity of myonecrosis after cardiac surgery. This may aid in preoperative identification of high-risk cardiac surgical patients and development of novel cardioprotective strategies.
BACKGROUND: The inflammatory response triggered by cardiac surgery with cardiopulmonary bypass (CPB) is a primary mechanism in the pathogenesis of postoperative myocardial infarction (PMI), a multifactorial disorder with significant inter-patient variability poorly predicted by clinical and procedural factors. We tested the hypothesis that candidate gene polymorphisms in inflammatory pathways contribute to risk of PMI after cardiac surgery. METHODS AND RESULTS: We genotyped 48 polymorphisms from 23 candidate genes in a prospective cohort of 434 patients undergoing elective cardiac surgery with CPB. PMI was defined as creatine kinase-MB isoenzyme level > or = 10x upper limit of normal at 24 hours postoperatively. A 2-step analysis strategy was used: marker selection, followed by model building. To minimize false-positive associations, we adjusted for multiple testing by permutation analysis, Bonferroni correction, and controlling the false discovery rate; 52 patients (12%) experienced PMI. After adjusting for multiple comparisons and clinical risk factors, 3 polymorphisms were found to be independent predictors of PMI (adjusted P<0.05; false discovery rate <10%). These gene variants encode the proinflammatory cytokine interleukin 6 (IL6 -572G>C; odds ratio [OR], 2.47), and 2 adhesion molecules: intercellular adhesion molecule-1 (ICAM1 Lys469Glu; OR, 1.88), and E-selectin (SELE 98G>T; OR, 0.16). The inclusion of genotypic information from these polymorphisms improved prediction models for PMI based on traditional risk factors alone (C-statistic 0.764 versus 0.703). CONCLUSIONS: Functional genetic variants in cytokine and leukocyte-endothelial interaction pathways are independently associated with severity of myonecrosis after cardiac surgery. This may aid in preoperative identification of high-risk cardiac surgical patients and development of novel cardioprotective strategies.
Authors: K Wenzel; R Stahn; A Speer; K Denner; C Gläser; M Affeldt; M Moobed; A Scheer; G Baumann; S B Felix Journal: Biol Chem Date: 1999-06 Impact factor: 3.915
Authors: Hua Tang; Tom Quertermous; Beatriz Rodriguez; Sharon L R Kardia; Xiaofeng Zhu; Andrew Brown; James S Pankow; Michael A Province; Steven C Hunt; Eric Boerwinkle; Nicholas J Schork; Neil J Risch Journal: Am J Hum Genet Date: 2004-12-29 Impact factor: 11.025
Authors: V Tomic; S Russwurm; E Möller; R A Claus; M Blaess; F Brunkhorst; M Bruegel; K Bode; F Bloos; J Wippermann; T Wahlers; H-P Deigner; J Thiery; K Reinhart; M Bauer Journal: Circulation Date: 2005-11-08 Impact factor: 29.690
Authors: Steve E Calvano; Wenzhong Xiao; Daniel R Richards; Ramon M Felciano; Henry V Baker; Raymond J Cho; Richard O Chen; Bernard H Brownstein; J Perren Cobb; S Kevin Tschoeke; Carol Miller-Graziano; Lyle L Moldawer; Michael N Mindrinos; Ronald W Davis; Ronald G Tompkins; Stephen F Lowry Journal: Nature Date: 2005-08-31 Impact factor: 49.962
Authors: D T Miller; R Y L Zee; J Suk Danik; P Kozlowski; D I Chasman; R Lazarus; N R Cook; P M Ridker; D J Kwiatkowski Journal: Ann Hum Genet Date: 2005-11 Impact factor: 1.670
Authors: Mihai V Podgoreanu; Gregory A Michelotti; Yukie Sato; Michael P Smith; Simon Lin; Richard W Morris; Hilary P Grocott; Joseph P Mathew; Debra A Schwinn Journal: J Thorac Cardiovasc Surg Date: 2005-08 Impact factor: 5.209
Authors: Ian J Welsby; Barbara Phillips-Bute; Joseph P Mathew; Mark F Newman; Richard Becker; Sunil Rao; Carmelo A Milano; Mark Stafford-Smith Journal: J Thromb Thrombolysis Date: 2014-10 Impact factor: 2.300